Moving Liposome Technology from the Bench to the Oncological Patient: Towards Performance-by-Design
- 7 September 2018
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironmentInternational Journal of Pharmaceutics, 2012
- Liposome preparation using a hollow fiber membrane contactor—Application to spironolactone encapsulationInternational Journal of Pharmaceutics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 2011
- Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting PropertiesJournal of Pharmaceutical Sciences, 2010
- Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancerLung Cancer, 2010
- Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid TumorsPharmaceutical Research, 2010
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Selective Filtering of Particles by the Extracellular Matrix: An Electrostatic BandpassBiophysical Journal, 2009
- Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposomeInternational Journal of Pharmaceutics, 2008